The ASA and the NCCAOM Support the Acupuncture for Our Seniors Act
July 30, 2021 15:22 ET
|
National Certification Commission for Acupuncture and Oriental Medicine
WASHINGTON, July 30, 2021 (GLOBE NEWSWIRE) -- The American Society of Acupuncturists (ASA) and the National Certification Commission for Acupuncture and Oriental Medicine (NCCAOM) are pleased to...
Novartis presents positive Phase III results from JUNIPERA study supporting Cosentyx® as a potential treatment in a JIA population at EULAR 2021
June 02, 2021 01:15 ET
|
Novartis Pharma AG
Phase III JUNIPERA study met its primary endpoint, with Cosentyx® (secukinumab) showing significantly longer time to flare (longer time to worsening of symptoms1) vs. placebo (P<.001) in pediatric...
Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis
June 01, 2021 16:30 ET
|
Novartis Pharma AG
Approval for moderate to severe pediatric patients six years and older is based on pivotal trial data showing Cosentyx demonstrated superior improvements of skin symptoms compared to placebo1 The...
“Return to Life” Documentary Reveals Neuro-Acupuncture Success
May 28, 2021 14:14 ET
|
National Certification Commission for Acupuncture and Oriental Medicine
SANTA FE, N.M., May 28, 2021 (GLOBE NEWSWIRE) -- New documentary “Return to Life” premiered internationally via Zoom on Friday, May 7, 2021. From award-winning director Doug Dearth (“9000 Needles”),...
Traditional Naturopath Shares Inspiring Journey to Healing from Addiction, Chronic Illness in Debut Memoir
January 19, 2021 07:00 ET
|
Balboa Press
GIBSON, La., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Author and traditional naturopath Michelle L. Potter has published her uplifting memoir that invites readers to share in Potter’s persistence and...
Seven Leading Non-Profit Providers Leverage Experience Treating Patients with Advanced Illness at Home for New, Unique Medicare Care Model
December 08, 2020 19:12 ET
|
Capital Caring
Falls Church, Virginia, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Seven of the nation’s largest and well-known non-profit advanced illness providers have formed Advanced Illness Partners (AIP) to...
Capital Caring Health Partners with Six Leading Non-Profit Providers to Leverage Experience Treating Patients with Advanced Illness at Home
December 07, 2020 16:59 ET
|
Capital Caring
Falls Church, Virginia, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Capital Caring Health has joined forces with six of the nation’s largest and well-known non-profit advanced illness providers to form...
Witness a true story of long-term suffering with chronic illness, addiction and Lyme disease transformed by the will to live
November 10, 2020 01:27 ET
|
Balboa Press
GIBSON, La., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Despite the debilitating pain, discomfort and mysterious symptoms that Michelle L. Potter had since childhood, doctors kept telling that there is...
Novartis Phase IIIb ARGON study meets primary endpoint in a comparison of Enerzair® Breezhaler® (QVM149) versus a free combination of two existing inhaled treatments in uncontrolled asthma
June 05, 2020 01:15 ET
|
Novartis International AG
Once-daily Enerzair® Breezhaler® (QVM149; IND/GLY/MF) met primary endpoint, demonstrating non-inferiority to a free combination of twice-daily Sal/Flu plus once-daily tiotropium (Tio), in improving...
Novartis announces data in Neurology reinforcing the real-world and long-term effectiveness and safety of Aimovig® as a preventive treatment across the full spectrum of migraine
April 16, 2020 01:15 ET
|
Novartis International AG
Real-world evidence supports benefits seen in Aimovig clinical trials Open-label data highlight long-term efficacy and safety profile of Aimovig in episodic and chronic migraine Post-hoc and...